Shoag J, Tasian GE, Goldfarb DS et al. The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis. 2015 Jul;22(4):273-8

Rendina D, De Filippo G et al. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014 Aug;27(4):371-6

Robertson WG. Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease. Urolithiasis. 2016 Feb;44(1):9-26

Prezioso D, Strazzullo P, Lotti T et al. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20

Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol. 2008 Sep;3(5):1453-60

Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007 Jul;18(7):2198-204

Traxer O, Huet B, Poindexter J et al. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. 2003; 170 :397– 401

Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004; 15 :3225-3232

Ferraro PM, Curhan GC et al. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. Am J Kidney Dis. 2016 Mar;67(3):400-7

Nguyen QV1, Kälin A, Drouve U et al. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. Kidney Int. 2001 Jun;59(6):2273-81

Siener R, Bangen U, Sidhu H et al. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int. 2013 Jun;83(6):1144-9

Mogna L, Pane M, Nicola S et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S91-5

Massey L. Magnesium therapy for nephrolithiasis. Magnes Res. 2005 Jun;18(2):123-6

Phillips R, Hanchanale VS et al. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015 Oct 6;10:CD010057

Eisner BH, Sheth S, Dretler SP et al. High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology. 2012 Oct;80(4):780-3

Friedlander JI, Antonelli JA, Pearle MS. Diet: from food to stone. World J Urol. 2015 Feb;33(2):179-85

Han H, Segal AM, Seifter JL et al. Nutritional management of kidney stones (nephrolithiasis). Clin Nutr Res. 2015 Jul;4(3):137-52

Nouvenne A, Meschi T, Prati B et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010 Mar;91(3):565-70

Ticinesi A, Nouvenne A, Maalouf NM et al. Salt and nephrolithiasis. Nephrol Dial Transplant. 2016 Jan;31(1):39-45

Giannini S, Nobile M, Sartori L et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr. 1999 Feb;69(2):267-71

Rotily M, Léonetti F, Iovanna C et al. Effects of low animal protein or high-fiber diets on urine composition in calcium nephrolithiasis. Kidney Int. 2000 Mar;57(3):1115-23

Nguyen QV, Kälin A, Drouve U, Casez JP, Jaeger P. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. Kidney Int. 2001 Jun;59(6):2273-8

Massey LK, Kynast-Gales SA. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones. J Am Diet Assoc. 2001 Mar;101(3):326-31

Kessler T, Jansen B, Hesse A. Effect of blackcurrant-, cranberry- and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr. 2002 Oct;56(10):1020-3

Karagülle O, Smorag U, Candir F et al. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis. World J Urol. 2007 Jun;25(3):315-23

Pinheiro VB, Baxmann AC, Tiselius HG et al. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers. Urology. 2013 Jul;82(1):33-7

Bruun JM, Maersk M, Belza A et al. Consumption of sucrose-sweetened soft drinks increases plasma levels of uric acid in overweight and obese subjects: a 6-month randomised controlled trial. Eur J Clin Nutr. 2015 Aug;69(8):949-53

Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int. 2008 Jan;73(2):207-12

Nguyen NU, Dumoulin G, Henriet MT et al. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res. 1995 Mar;27(3):155-8

Nguyen NU, Dumoulin G et al. Urinary calcium and oxalate excretion during oral fructose or glucose load in man. Horm Metab Res. 1989 Feb;21(2):96-9

Ferraro PM, Taylor EN et al. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013 Aug;8(8):1389-95

Boonla C, Hunapathed C, Bovornpadungkitti S et al. Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys. BJU Int. 2008 May;101(9):1170-7

Siener R, Jansen B, Watzer B et al. Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation. J Urol. 2011 Feb;185(2):719-24

Yasui T, Suzuki S, Itoh Y et al. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Urol Int. 2008;81(2):135-8

Ortiz-Alvarado O, Miyaoka R, Kriedberg C et al. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology. 2012 Feb;79(2):282-6

Stoller ML, Chi T, Eisner BH et al. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol. 2009 Mar;181(3):1140-4

Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis. 2006 Oct;48(4):546-54

Kirdpon S, Kirdpon W, Airarat W et al. Effect of aloe (Aloe vera Linn.) on healthy adult volunteers: changes in urinary composition. J Med Assoc Thai. 2006 Aug;89 Suppl 2:S9-14

Brymora A, Flisiński M, Johnson RJ et al. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant. 2012 Feb;27(2):608-12

Shi Y, Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial. Br J Nutr. 2016 Mar;115(5):800-6

Manfredini R, De Giorgi A et al. Pears and renal stones: possible weapon for prevention? A comprehensive narrative review. Eur Rev Med Pharmacol Sci. 2016 Feb;20(3):414-25

Naghii MR, Babaei M, Hedayati M. Androgens involvement in the pathogenesis of renal stones formation. PLoS One. 2014 Apr 2;9(4):e93790

Wang H, Man L, Li G et al. Association between serum vitamin D levels and the risk of kidney stone: evidence from a meta-analysis. Nutr J. 2016 Mar 31;15:32

Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014 Sep 1;3(3):256-276

Al-Awadi KA, Kehinde EO et al. Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants. Urol Res. 2008 Feb;36(1):51-60

Kehinde EO, Al-Awadi KA, Al-Hunayan A et al. Antioxidant therapy is associated with a reduction in the serum levels of mediators of renal injury following lithotripsy for renal calculi. J Endourol. 2008 Nov;22(11):2537-45

Modi J, Modi P, Pal B et al. Role of Vitamin C and E supplementation in reduction of serum level of renal injury marker following shock wave lithotripsy: Prospective single centre experience. Urol Ann. 2015 Jul-Sep;7(3):350-4

Stern JM, Moazami S, Qiu Y et al. Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. Urolithiasis. 2016 Apr 26. [Epub ahead of print]

Turney BW, Appleby PN, Reynard JM et al. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014 May;29(5):363-9

Hirayama H, Wang Z, Nishi K et al. Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones. Br J Urol. 1993 Feb;71(2):143-7

Koide T, Yamaguchi S et al. The inhibitory effect of kampou extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model. Int J Urol. 1995 May;2(2):81-6

Lin E, Ho L, Lin MS et al. Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial. Afr J Tradit Complement Altern Med. 2013 Aug 12;10(5):199-209

Nishihata M, Kohjimoto Y, Hara I. Effect of Kampo extracts on urinary stone formation: an experimental investigation. Int J Urol. 2013 Oct;20(10):1032-6

Sheng B, He D, Zhao J et al. The protective effects of the traditional Chinese herbs against renal damage induced by extracorporeal shock wave lithotripsy: a clinical study. Urol Res. 2011 Apr;39(2):89-97

Faridi P, Seradj H, Mohammadi-Samani S et al. Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. J Ethnopharmacol. 2014 Oct 28;156:82-7

Duffin C. Lapis Judaicus or the Jews' stone: The folklore of fossil echinoid spines. Proceedings of the Geologists Association. 2006; 117(3):265-275

Singh RG, Behura SK, Kumar R. Litholytic property of Kulattha (Dolichous biflorus) vs potassium citrate in renal calculus disease: a comparative study. J Assoc Physicians India. 2010 May;58:286-9

Brardi S, Imperiali P, Cevenini G et al. Effects of the association of potassium citrate and agropyrum repens in renal stone treatment: results of a prospective randomized comparison with potassium citrate. Arch Ital Urol Androl. 2012 Jun;84(2):61-7

Boim MA, Heilberg IP, Schor N. Phyllanthus niruri as a promising alternative treatment for nephrolithiasis. Int Braz J Urol. 2010 Nov-Dec;36(6):657-64

Premgamone A, Sriboonlue P et al. A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):654-60

Erickson SB, Vrtiska TJ et al. Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res. 2011 Jun;39(3):197-203

Erickson SB, Vrtiska TJ, Lieske JC. Effect of Cystone® on urinary composition and stone formation over a one year period. Phytomedicine. 2011 Jul 15;18(10):863-7

Shekar Kumaran MG, Patki PS. Evaluation of an Ayurvedic formulation (Cystone), in urolithiasis: A double blind, placebo-controlled study. Eur J Integr Med. 2011; 3:23-28.

Mohanty NK, Nayak RL, Patki PS. Safety and Efficacy of an Ayurvedic Formulation Cystone in Management of Ureteric Calculi: A Prospective Randomized Placebo Controlled Study. Am J Pharmacol Toxicol. 2010; 5:58-64

Singh RG, Singh TB et al. A comparative pilot study of litholytic properties of Celosia argental (Sitivaraka) versus potassium citrate in renal calculus disease. J Altern Complement Med. 2012 May;18(5):427-8

Patankar S, Dobhada S et al. A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation "varuna and banana stem" in the management of urinary stones. J Altern Complement Med. 2008 Dec;14(10):1287-90

Dinesh V et al. Herbal formulations used in treatment of kidney stone by native folklore of Nizamabad District, Andhra Pradesh, India. Bioscience Discovery. 2013; 4(2):250-253

Chitme HR et al. Herbel treatment for urinary stones. IJPSR. 2010; 1(2):24-31

Nasim MJ, Bin Asad MH, Durr-e-Sabih et al. Gist of medicinal plants of Pakistan having ethnobotanical evidences to crush renal calculi (kidney stones). Acta Pol Pharm. 2014 Jan-Feb;71(1):3-10

Atmani F. Medical management of urolithiasis, what opportunity for phytotherapy? Front Biosci. 2003 May 1;8:s507-14

Grases F, Melero G et al. Urolithiasis and phytotherapy. Int Urol Nephrol. 1994;26(5):507-11